GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accent Microcell Ltd (NSE:ACCENTMIC) » Definitions » Debt-to-Equity

Accent Microcell (NSE:ACCENTMIC) Debt-to-Equity : 0.52 (As of Mar. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Accent Microcell Debt-to-Equity?

Accent Microcell's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was ₹173 Mil. Accent Microcell's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was ₹55 Mil. Accent Microcell's Total Stockholders Equity for the quarter that ended in Mar. 2023 was ₹442 Mil. Accent Microcell's debt to equity for the quarter that ended in Mar. 2023 was 0.52.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Accent Microcell's Debt-to-Equity or its related term are showing as below:

NSE:ACCENTMIC' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.52   Med: 0.75   Max: 1.15
Current: 0.52

During the past 3 years, the highest Debt-to-Equity Ratio of Accent Microcell was 1.15. The lowest was 0.52. And the median was 0.75.

NSE:ACCENTMIC's Debt-to-Equity is ranked worse than
66.47% of 844 companies
in the Drug Manufacturers industry
Industry Median: 0.3 vs NSE:ACCENTMIC: 0.52

Accent Microcell Debt-to-Equity Historical Data

The historical data trend for Accent Microcell's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accent Microcell Debt-to-Equity Chart

Accent Microcell Annual Data
Trend Mar21 Mar22 Mar23
Debt-to-Equity
1.15 0.75 0.52

Accent Microcell Semi-Annual Data
Mar21 Mar22 Mar23
Debt-to-Equity 1.15 0.75 0.52

Competitive Comparison of Accent Microcell's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Accent Microcell's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accent Microcell's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Accent Microcell's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Accent Microcell's Debt-to-Equity falls into.


Accent Microcell Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Accent Microcell's Debt to Equity Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(173.083 + 54.741) / 441.991
=0.52

Accent Microcell's Debt to Equity Ratio for the quarter that ended in Mar. 2023 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(173.083 + 54.741) / 441.991
=0.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accent Microcell  (NSE:ACCENTMIC) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Accent Microcell Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Accent Microcell's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Accent Microcell (NSE:ACCENTMIC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accent Microcell Ltd (NSE:ACCENTMIC) » Definitions » Debt-to-Equity
Comparable Companies
Traded in Other Exchanges
N/A
Address
Shyamal Cross Roads, Anandnagar Road, 314, Shangrilla Arcade, Satellite, Ahmedabad, GJ, IND, 380015
Website
https://www.accentmicrocell.com
Accent Microcell Ltd is a manufacturer of Pharmaceutical Products. It has Products such as Microcrystalline cellulose is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production; Cross Carmellose Sodium Croscarmellose sodium is an internally cross-linked sodium carboxymethylcellulose for use as a super disintegrant in pharmaceutical formulations; Magnesium Stearate which is also called octadecanoic acid, magnesium salt, is a white substance, powder which becomes solid at room temperature and also produces Cellulose Powder is white or almost white, odourless, tasteless, Practically insoluble in water, dilute acid and organic solvents, Slightly soluble in dilute NaOH solution.

Accent Microcell (NSE:ACCENTMIC) Headlines

No Headlines